Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-08-24 Sale |
2023-08-25 4:30 pm |
Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer |
33,000 | $2.33 | $76,890 | 258,042 (Direct) |
View |
| 2022-08-23 Sale |
2022-08-24 4:47 pm |
Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer |
3,325 | $3.47 | $11,538 | 266,121 (Direct) |
View |
| 2022-08-18 Sale |
2022-08-22 8:05 pm |
Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer |
28,675 | $3.6966 | $105,999 | 269,446 (Direct) |
View |
| 2021-08-18 Sale |
2021-08-20 5:52 pm |
Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer |
33,000 | $16.88 | $557,023 | 298,121 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-05-31 Option Award(A) |
2025-04-10 4:15 pm |
N/A 2033-02-02 |
Taysha Gene Therapies Inc. | TSHA | Alam Kamran CHIEF FINANCIAL OFFICER |
12,462 | $0 | 12,462 (Direct) |
View |
| 2025-03-11 Tax Withholding |
2025-03-13 4:15 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | Alam Kamran CHIEF FINANCIAL OFFICER |
29,843 | $1.69 | 1,242,094 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 5:31 pm |
N/A 2035-01-02 |
Taysha Gene Therapies Inc. | TSHA | Alam Kamran CHIEF FINANCIAL OFFICER |
431,000 | $0 | 1,702,937 (Direct) |
View |
| 2024-02-02 Tax Withholding |
2024-02-06 4:42 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | Alam Kamran CHIEF FINANCIAL OFFICER |
1,288 | $1.51 | 840,937 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:43 pm |
N/A 2034-01-02 |
Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer |
590,413 | $0 | 1,432,638 (Direct) |
View |
| 2023-12-14 Option Award |
2023-12-18 4:50 pm |
N/A 2033-12-14 |
Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer |
187,582 | $0 | 187,582 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 4:12 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer |
6,230 | $0 | 291,042 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-06 9:12 pm |
N/A 2033-02-02 |
Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer |
205,975 | $0 | 472,096 (Direct) |
View |
| 2022-04-06 Option Award |
2022-04-08 4:27 pm |
N/A 2032-04-06 |
Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-02-23 Option Award |
2022-02-25 4:18 pm |
N/A 2032-02-23 |
Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer |
80,000 | $0 | 80,000 (Direct) |
View |
| 2021-01-19 Option Award |
2021-01-20 8:20 pm |
N/A 2031-01-19 |
Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer |
70,000 | $0 | 70,000 (Direct) |
View |
| 2020-09-23 Option Award |
2020-09-25 5:08 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer |
331,121 | $0 | 331,121 (Direct) |
View |